Lorundrostat shows continued promise against uncontrolled hypertension - report from ACC.25

Luke Laffin on the phase 2b Advance-HTN study of lorundrostat, whose results were reported in a late-breaking clinical trials presentation at the American College of Cardiology’s 2025 Scientific Session.Video: https://medicaldigest.org/scientific-contents/interview:lorundrostat-shows-continued-promise-against-uncontrolled-hypertension

Om Podcasten

The MedicalDigest.org / CongressReport.eu podcast covers the latest evidence based medical news from cardiology, hematology, oncology, diabetology, pulmonology, dermatology, urology and more. Made for healthcare professionals and researchers, we are an independent, open-access platform. CongressReport.eu portal enables HCPs to get acquainted with new clinical trial results, medical diagnostic and treatment guidelines. Our non-promotional website collects and stores the relevant scientific information, KOL insights, key lectures, poster presentations in a user-friendly format.